glp-1 mitochondria improves the neuronal supportive ability of astrocytes in Alzheimer's disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway GLP-1 agonists in pediatric obesity:

It reports probiotic weight changes of roughly 1 to 5 percent in published human studies, but cautions that adherence and microbiome variability complicate interpretation, so the gap it describes comes from separate trials rather than a head-to-head design

Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome

We'll build a treatment plan tailored to your goals

By potentially reducing nausea and supporting energy levels, it helps patients stay consistent with their treatment and maintain an active lifestyle, which are key drivers of long-term results